You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The proposed $540 million acquisition gives Sydney-based Sonic Healthcare greater scale and a larger geographic presence in the US laboratory market.
The company will rely more on distribution partners in Europe for its Unyvero product line while continuing highly targeted commercialization efforts in the US.
The company expects EPS to be between $4.02 and $4.12. On a non-GAAP basis, EPS is expected to be in the range of $4.75 and $4.85.
Sysmex accuses 13 Beckman Coulter instruments of infringing 11 claims in the patent, which covers a system analyzer and a computer program.
A recent study highlights the ability of the company's prognostic tool to detect levels of circulating tumor cells in angiosarcoma patients.
The mass spectrometry-based tests measure the level of five proteins in patient serum to assess cholesterol efflux capacity and risk of coronary artery disease.
The amicus briefs challenge the method in which HHS collected data to establish market-based Medicare prices and found flaws in a district court decision dismissing the case.
With the approval Sera is permitted to provide lab testing services ordered by a medical professional for use by pregnant women in all US states.
The company also said that it received ISO 13485:2016 certification for its Mosaiq platform and it has filed for CE marking for its initial immunohematology microarray.
ChromaCode this week launched its first product, a research-use-only test for nine tick-borne pathogens designed for research use on any thermal cycler.